Neurontin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0071-2012
  • Package NDC 0071-2012-47
  • Application number NDA021129
  • SPL ID e730d5df-d47b-4d7f-ae3b-bd449f6b1213
  • SPL set ID ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388
  • UNII 6CW7F3G59X
  • RxCUI 105028
  • RxCUI 105029
  • RxCUI 105030
  • RxCUI 261280
  • RxCUI 261281
  • RxCUI 283523
  • RxCUI 310430
  • RxCUI 310431
  • RxCUI 310432
  • RxCUI 310433
  • RxCUI 310434
  • RxCUI 351973

What the source publishes

Labeler
Parke-Davis Div of Pfizer Inc
Active ingredients
gabapentin
Form
SOLUTION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0071-2012_e730d5df-d47b-4d7f-ae3b-bd449f6b1213
{
  "name": "Neurontin",
  "splId": "e730d5df-d47b-4d7f-ae3b-bd449f6b1213",
  "labels": [
    {
      "setId": "ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Parke-Davis Div of Pfizer Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE, PLASTIC in 1 CARTON (0071-2012-47)  / 470 mL in 1 BOTTLE, PLASTIC",
      "package_ndc": "0071-2012-47",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20270131",
      "marketing_start_date": "20220712"
    }
  ],
  "productId": "0071-2012_e730d5df-d47b-4d7f-ae3b-bd449f6b1213",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION",
  "productNdc": "0071-2012",
  "deaSchedule": null,
  "genericName": "gabapentin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20270131",
  "activeIngredients": [
    {
      "name": "GABAPENTIN",
      "strength": "250 mg/5mL"
    }
  ],
  "applicationNumber": "NDA021129",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20000302",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "upc": [
      "0300710513242"
    ],
    "unii": [
      "6CW7F3G59X"
    ],
    "rxcui": [
      "105028",
      "105029",
      "105030",
      "261280",
      "261281",
      "283523",
      "310430",
      "310431",
      "310432",
      "310433",
      "310434",
      "351973"
    ],
    "spl_set_id": [
      "ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "Parke-Davis Div of Pfizer Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0071-2012_e730d5df-d47b-4d7f-ae3b-bd449f6b1213"